Molecular epidemiology of an outbreak due to extended-spectrum beta-lactamase-producing enterobacteria in a French hospital

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 16, Issue 7, 1997, Pages 523-529

  Bermudes, H ^a   Arpin, C ^a   Jude, F ^a   El Harrif, Z ^a   Bebear C ^b   Quentin, C ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Centre Nat'l Ref Campylobacters   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE;

ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; CITROBACTER; CONTROLLED STUDY; DNA HYBRIDIZATION; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; EPIDEMIC; ESCHERICHIA COLI; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NEUROSURGERY; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; DNA, BACTERIAL; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; EPIDEMIOLOGY, MOLECULAR; FRANCE; HUMANS; ISOELECTRIC FOCUSING; MICROBIAL SENSITIVITY TESTS; PLASMIDS; POLYMERASE CHAIN REACTION;

EID: 0030792401     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01708236     Document Type: Article

References (21)

1. Philippen A: Ben Redjeb S, Fournier G, Ben Hassen A: Epidemiology of extended spectrum β-lactamases. Infection 1989, 17: 347-354.
2. Jacoby GA, Sutton L: Properties of plasmids responsible for production of extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 1991, 35: 164-169.
3. Mariotte S, Nordmann P, Nicolas MH: Extended-spectrum β-lactamase in Proteus mirabilis. Journal of Antimicrobial Chemotherapy 1994, 33: 925-935.
4. Philippon A, Ariel G, Lagrange P: Origin and impact of plasmid-mediated extended-spectrum β-lactamases. European Journal of Clinical Microbiology & Infectious Diseases 1994, Supplement 1: 17-29.
5. Arlet G, Rouveau M, Casin I, Bouvet PJM, Lagrange PH, Philippon A: Molecular epidemiology of Klebsiella pneumoniae strains that produce SHV-4 β-lactamase and which were isolated in 14 French hospitals. Journal of Clinical Microbiology 1994, 32: 2553-2558.
6. Petit A, Gerbaud G, Sirot D, Courvalin P, Sirot J: Molecular epidemiology of TEM-3 (CTX-1) β-lactamase. Antimicrobial Agents and Chemotherapy 1990, 34: 219-224.
7. Prodinger WM, Fille M, Bauernfeind A, Stemplinger I, Amann S, Pfausler B, Lass-Flörl C, Dierich P: Molecular epidemiology of Klebsiella pneumoniae producing SHV-5 β-lactamase: parallel outbreaks due to multiple plasmid transfer. Journal of Clinical Microbiology 1996, 34: 564-568.
8. Arlet G, Sanson-Le Pors MJ, Rouveau M, Fournier G, Marie O, Schlemmer B, Philippon A: Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase. European Journal of Clinical Microbiology & Infectious Diseases 1990, 9: 797-803.
9. Jarlier V, Nicolas MH, Fournier G, Philippon A: Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Reviews of Infectious Diseases 1988, 10: 867-878.
10. Courvalin P, Goldstein F, Philippon A, Sirot J: L'antibiogramme. MPC-Videom, Paris, 1985, p. 195-198.
11. Matthew M, Harris AM, Marshall MJ, Ross GW: The use of analytical isoelectric focusing for detection and identification of β-lactamases. Journal of General Microbiology 1975, 88: 169-178.
12. Birnboim HC, Doly J: A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Research 1979, 7: 1513-1523.
13. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. Journal of Molecular Biology 1975, 98: 503-517.
14. Nicolas MH, Jarlier V, Honore N, Philippen A, Cole ST: Molecular characterization of the gene encoding SHV-3 β-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy 1989, 33: 2096-2100.
15. Arpin C, Coze C, Rogues AM, Gachie JR Bébéar C, Quentin C: Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. Journal of Clinical Microbiology 1996, 34:2163-2169.
16. Philippon A, Labia R, Jacoby G: Extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 1989, 33: 1131-1136.
17. Sirot D: Extended-spectrum plasmid-mediated β-lactamases. Journal of Antimicrobial Chemotherapy 1995, 36, Supplement A: 19-34.
18. Soilleux MJ, Morand AM, Arlet G, Scavizzi M, Labia R: Survey of Klebsiella pneumoniae producing extended-spectrum β-lactamases: prevalence of TEM-3 and first identification of TEM-26 in France. Antimicrobial Agents and Chemotherapy 1996, 40: 1027-1029.
19. Jacoby GA, Medeiros AA: More extended-spectrum β-lactamases. Antimicrobial Agents and Chemotherapy 1991, 35: 1697-1704.
20. Bingen EH, Desjardins P, Arlet G, Bougeois F, Mariani-Kurkdjian P, Lambert-Zechovski NY, Denamur E, Philippon A, Elion J: Molecular epidemiology of plasmid spread among extended broad-spectrum β-lactamase producing Klebsiella pneumoniae isolates in a pediatric hospital. Journal of Clinical Microbiology 1993, 31: 179-184.
21. Livermore DM, Yuan M: Antibiotic resistance and production of extended-spectrum β-lactamases among Klebsiella spp. from intensive care units in Europe. Journal of Antimicrobial Chemotherapy 1996, 38: 409-424.